Category: Upper Gastrointestinal Tract

High variability in VTE risk across abdominal surgery procedures, impacting thromboprophylaxis decisions

The study conducted systematic reviews and meta-analyses to estimate procedure-specific risks of symptomatic venous thromboembolism (VTE) and major bleeding after various types of abdominal surgery. They found that the risk of VTE varied widely among different procedures, with laparoscopic cholecystectomy having the lowest median risk (

Successful Endoscopic Submucosal Dissection for Barrett’s Neoplasia

Complete circumferential endoscopic submucosal dissection (ESD) was performed on 11 patients with early Barrett’s neoplasia in a Canadian referral center. All procedures were technically successful with en-bloc resection. Nine patients achieved clear margins, while two required esophagectomy due to positive deep margins. The final pathology revealed adenocarcinoma in seven patients, with six cases showing upstaging […]

Telehealth intervention shows potential to improve quality of life for patients with eating symptoms after gastroesophageal cancer surgery

Researchers conducted a pilot study to assess the effectiveness of a telehealth intervention for personalized self-management of eating symptoms after gastroesophageal cancer surgery. The intervention, delivered by a nutritionist through telehealth sessions over 4 months, demonstrated feasibility and acceptability among patients. Although the differences between the intervention and control groups were not statistically significant, the […]

Indocyanine Green Fluorescence in Minimally Invasive Esophagectomy: Predictive Potential and Complication Rates

Indocyanine green fluorescence (IGF) can be used to predict anastomotic complications during minimally invasive esophagectomy (MIE), although its use may be associated with an increased rate of anastomotic leaks and higher mortality. A study of 181 patients undergoing MIE found that patients who underwent IGF evaluation had a higher rate of anastomotic leak compared to […]

Combined use of tumor markers improves prognostic accuracy in gastric cancer

This study evaluated the combined use of three tumor markers (CEA, CA72-4, and CA19-9) for prognostic assessment in gastric cancer patients. Data from 1,966 patients who underwent curative gastrectomy were analyzed, and hazard ratios were calculated. The results showed that the combined use of tumor markers significantly improved prognostic accuracy compared to using a single […]

Comparison of Short-Term Outcomes of Esophagojejunal Anastomotic Techniques during Laparoscopic Total Gastrectomy

Based on a network meta-analysis of 20 studies involving 3,177 patients, the study found that different esophagojejunal anastomotic techniques during laparoscopic total gastrectomy (LTG) for gastric cancer have comparable rates of anastomotic leakage and stenosis. No significant differences were observed in anastomotic bleeding, operative time, time to soft diet resumption, pulmonary complications, hospital length of […]

Safety and Efficacy of Robotic Distal Gastrectomy for Gastric Cancer in Japan

Real-world evidence from a large-scale database in Japan shows that robotic distal gastrectomy (RDG) for gastric cancer is safe and effective. RDG has comparable in-hospital mortality and postoperative complication rates to laparoscopic distal gastrectomy (LDG), but RDG is associated with a longer duration of anesthesia, similar time to diet resumption, and shorter postoperative length of […]

Minimally Invasive Gastrectomy A Safe Alternative to Open Gastrectomy for Advanced Gastric Cancer in Western Countries

Minimally invasive gastrectomy (MIG) shows comparable postoperative recovery, oncological outcomes, and quality of life to open gastrectomy (OG) in patients with advanced gastric cancer in Western countries. A pooled analysis of two European randomized controlled trials found MIG to be a safe alternative to OG, with MIG showing lower blood loss but longer surgery duration […]

Optimistic Long-Term Outcomes for Esophageal Cancer Patients with Pathologic Complete Response after Neoadjuvant Chemotherapy and Surgery

Patients with locally advanced esophageal squamous cell carcinoma (ESCC) who achieved a pathologic complete response (PCR) after neoadjuvant chemotherapy had a favorable prognosis in terms of long-term survival. The 5-year overall survival rate for patients with PCR was significantly higher compared to those without PCR. However, a subset of patients still experienced recurrence, particularly locoregional […]

Impact of Tumor Size on Survival Outcome in Esophageal Squamous Cell Carcinoma

The study evaluated the influence of tumor size on the prognosis of patients with esophageal squamous cell carcinoma (ESCC) undergoing esophagectomy after neoadjuvant chemotherapy. A total of 272 patients were categorized based on tumor size, with 36mm being the cut-off. Patients with tumor size ≥ 36mm had worse histological response and deeper tumor invasion. In […]